KDM4B and cancer: In addition, the recent report has identified that combination of expression levels of a hypoxic marker and JMJD2B predict patient survival [35].We thus believe that further characterization of JMJD2B and related signaling components may identify therapeutic targets and prognostic markers for human cancers.